Epsilon M&A Deal Report - Groupe Neroli
Transaction Multiples for the Valuation of Private Companies

Symrise > Groupe Neroli
Announced Date : 22 March 2022
Type : Acquisition of Majority Stake
Deal Value : Yes
Acquirer : Symrise
Target: Groupe Neroli
Target Country: France
Sector of activity : Health, Pharmaceuticals & Biotechnology, Chemicals
Business Description :
> Neroli Invest DL (Groupe Neroli) was formed by the merger of perfume h ...

Transaction multiples available
EV/Sales | EV/Gross Profit | EV/EBITDA | EV/EBIT | Eq/PBT | P/E | Price to Book | |
---|---|---|---|---|---|---|---|
Historic | |||||||
Current |
: Multiple available
n.s : Multiple calculated, but not significant
Rating **
Source: Epsilon Research / EMAT

Comparable Transactions
Number of EMAT Reports : (Chemicals) = 296
Example of comparable transactions on EMAT (same sub-sector):
Date | Acquirer | Target | Country | Multiples | See details |
---|---|---|---|---|---|
22/03/2022 | Symrise | Essence Ciel (SFA Romani) | France | 0 | |
17/07/2024 | Private group led by Geneo Capital Entrepreneur, Eximium, Bpifrance | Otego | France | 0 |
Source: Epsilon Research / EMAT
This report is accessible on EMAT, the reference database for private company acquisition multiples
Example of EMAT Report : click here
View Complete ReportEpsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.
Sectors covered by our analysts
Studies & indices published by Epsilon Research Register to receive (free) publications updates
Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).
Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.
Subscribe to EMAT database